Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Thorac Cardiovasc Surg ; 71(4): 327-335, 2023 06.
Article in English | MEDLINE | ID: mdl-35785811

ABSTRACT

BACKGROUND: Pulmonary complications are the most common adverse event after lung resection, yet few large-scale studies have examined pertinent risk factors after video-assisted thoracoscopic surgery (VATS) lobectomy. Veterans, older and less healthy compared with nonveterans, represent a cohort that requires further investigation. Our objective is to determine predictors of pulmonary complications after VATS lobectomy in veterans. METHODS: A retrospective review was conducted on patients who underwent VATS lobectomy from 2008 to 2018 using the Veterans Affairs Surgical Quality Improvement Program database. Patients were divided into two cohorts based on development of a pulmonary complication within 30 days. Patient characteristics were compared via multivariable analysis to determine clinical predictors associated with pulmonary complication and reported as adjusted odds ratios (aORs) with 95% confidence intervals. Patients with preoperative pneumonia, ventilator dependence, and emergent cases were excluded. RESULTS: In 4,216 VATS lobectomy cases, 480 (11.3%) cases had ≥1 pulmonary complication. Preoperative factors independently associated with pulmonary complication included chronic obstructive pulmonary disease (COPD) (aOR = 1.37 [1.12-1.69]; p = 0.003), hyponatremia (aOR = 1.50 [1.06-2.11]; p = 0.021), and dyspnea (aOR = 1.33 [1.06-1.66]; p = 0.013). Unhealthy alcohol consumption was associated with pulmonary complication via univariable analysis (17.1 vs. 13.0%; p = 0.016). Cases with pulmonary complication were associated with increased mortality (12.1 vs. 0.8%; p < 0.001) and longer length of stay (12.0 vs. 6.8 days; p < 0.001). CONCLUSION: This analysis revealed several preoperative factors associated with development of pulmonary complications. It is imperative to optimize pulmonary-specific comorbidities such as COPD or dyspnea prior to VATS lobectomy. However, unhealthy alcohol consumption and hyponatremia were linked with development of pulmonary complication in our analysis and should be addressed prior to VATS lobectomy. Future studies should explore long-term consequences of pulmonary complications.


Subject(s)
Hyponatremia , Lung Neoplasms , Pulmonary Disease, Chronic Obstructive , Humans , Lung Neoplasms/surgery , Thoracic Surgery, Video-Assisted/adverse effects , Hyponatremia/complications , Hyponatremia/surgery , Pneumonectomy/adverse effects , Treatment Outcome , Postoperative Complications/etiology , Pulmonary Disease, Chronic Obstructive/complications , Retrospective Studies , Length of Stay , Lung , Dyspnea/complications , Dyspnea/surgery
3.
Surg Clin North Am ; 102(3): 499-516, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35671770

ABSTRACT

Although the mortality of coronary artery disease (CAD) has declined over recent decades, CAD remains the leading cause of death in the United States (US) and presents a significant economic burden. Epidemiologic studies have identified numerous risk factors for CAD. Some risk factors-including smoking, hypertension, dyslipidemia, and physical inactivity-are decreasing within the US population while Others, including advanced age, diabetes, and obesity are increasing. The most significant historic advances in CAD therapy were the development of coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and lipid-lowering medications. Contemporary management of CAD includes primary and secondary prevention via medical management and revascularization when appropriate based on best available evidence. Despite the increasing prevalence of CAD nationwide, there has been a steady decline in the number of CABGs and PCIs performed in the US for the past decade. Patients with CABG are becoming older and with more comorbid conditions, although mortality associated with CABG has remained steady.


Subject(s)
Coronary Artery Disease , Percutaneous Coronary Intervention , Coronary Artery Bypass/adverse effects , Coronary Artery Disease/epidemiology , Coronary Artery Disease/etiology , Coronary Artery Disease/therapy , Humans , Percutaneous Coronary Intervention/adverse effects , Risk Factors , Treatment Outcome
4.
Surg Clin North Am ; 102(3): 517-528, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35671771

ABSTRACT

Acquired diseases of the aortic and mitral valves are the most common cause of morbidity and mortality among Valvular heart diseases. Aortic stenosis (AS) is increasing in incidence in the United States (4,43 US), driven largely by an aging demographic. Aortic valve replacement is the only effective treatment of AS and has a dramatic mortality benefit. Mitral valve regurgitation (MR) is the most common form of valvular heart disease (VHD) in the US, whereby MR is most often the result of mitral valve prolapse; rheumatic heart disease (RHD) is a more common etiology of MR in underdeveloped countries. interventions for MR in the US are increasing.


Subject(s)
Aortic Valve Stenosis , Heart Valve Diseases , Heart Valve Prosthesis , Mitral Valve Insufficiency , Aortic Valve Stenosis/epidemiology , Aortic Valve Stenosis/etiology , Aortic Valve Stenosis/surgery , Heart Valve Diseases/epidemiology , Heart Valve Diseases/etiology , Heart Valve Diseases/surgery , Heart Valve Prosthesis/adverse effects , Humans , Mitral Valve , Mitral Valve Insufficiency/epidemiology , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/surgery
SELECTION OF CITATIONS
SEARCH DETAIL